Protagonist Therapeutics Inc (PTGX)
30.74
-1.20
(-3.76%)
USD |
NASDAQ |
May 17, 16:00
30.74
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Total Return Level: 30.74 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 30.74 |
May 16, 2024 | 31.94 |
May 15, 2024 | 31.47 |
May 14, 2024 | 29.61 |
May 13, 2024 | 29.32 |
May 10, 2024 | 28.23 |
May 09, 2024 | 28.27 |
May 08, 2024 | 27.11 |
May 07, 2024 | 25.79 |
May 06, 2024 | 26.06 |
May 03, 2024 | 26.09 |
May 02, 2024 | 25.54 |
May 01, 2024 | 25.56 |
April 30, 2024 | 25.11 |
April 29, 2024 | 25.56 |
April 26, 2024 | 25.15 |
April 25, 2024 | 24.66 |
April 24, 2024 | 25.70 |
April 23, 2024 | 26.85 |
April 22, 2024 | 26.61 |
April 19, 2024 | 25.61 |
April 18, 2024 | 25.22 |
April 17, 2024 | 25.57 |
April 16, 2024 | 26.11 |
April 15, 2024 | 26.58 |
Date | Value |
---|---|
April 12, 2024 | 27.04 |
April 11, 2024 | 27.66 |
April 10, 2024 | 27.88 |
April 09, 2024 | 29.13 |
April 08, 2024 | 28.09 |
April 05, 2024 | 28.00 |
April 04, 2024 | 27.65 |
April 03, 2024 | 28.07 |
April 02, 2024 | 27.99 |
April 01, 2024 | 28.28 |
March 28, 2024 | 28.93 |
March 27, 2024 | 28.48 |
March 26, 2024 | 28.00 |
March 25, 2024 | 27.89 |
March 22, 2024 | 28.03 |
March 21, 2024 | 28.35 |
March 20, 2024 | 28.88 |
March 19, 2024 | 28.82 |
March 18, 2024 | 28.46 |
March 15, 2024 | 28.98 |
March 14, 2024 | 28.35 |
March 13, 2024 | 30.20 |
March 12, 2024 | 29.87 |
March 11, 2024 | 30.12 |
March 08, 2024 | 30.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
4.69
Minimum
Dec 03 2019
49.69
Maximum
Sep 01 2021
19.97
Average
18.95
Median
Oct 30 2020
Total Return Level Benchmarks
Lifecore Biomedical Inc | 5.87 |
SELLAS Life Sciences Group Inc | 1.46 |
Akebia Therapeutics Inc | 1.15 |
Immuneering Corp | 1.47 |
Moderna Inc | 132.90 |